Log In
BCIQ
Print this Print this
 

Lamictal, lamotrigine

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionSodium channel inhibitor
Molecular Target Sodium channel
Mechanism of ActionNa channel blocker
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$270.2M

$270.2M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/27/2012

$270.2M

$270.2M

0

Get a free BioCentury trial today